Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCEA vs LIA in Knee Arthroplasty
NCT02478372Completed
- Sponsor
- Golden Jubilee National Hospital
- Start
- Apr 2010
- Primary completion
- Aug 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in osteoarthritis (OA) (2 arms), sponsored by Golden Jubilee National Hospital. Primary endpoint: Proportion of Patients Discharged From Rehabilitation by Day Four at 96 hours. Started Apr 2010; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02478372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478372.